Lower risk Drug recall · FDA · Published March 8, 2022

Jubilant Cadista Meclizine Tablets Recall: Incorrect Labeling Risk

Jubilant Cadista recalls Meclizine Hydrochloride Tablets with incorrect Prednisone labeling. This mix-up could lead to wrong medication use. Consumers should check labels and contact the manufacturer for details.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0767-2022Drug Jubilant Cadista ›

Lower-risk recall

Labeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled as PredniSONE Tablets. The tablets in the bottles are Meclizine Hydrochloride

Take action

Contact the company

Recalling firmJubilant Cadista Pharmaceuticals, Inc.207 Kiley Dr · Salisbury, MD 21801-2249

✎ GovInfoNow plain-language explainer

Jubilant Cadista is recalling Meclizine Hydrochloride Tablets that have been incorrectly labeled as Prednisone. This mix-up could cause someone to take the wrong medication, which might lead to health risks. Read more at govinfonow.com/recall/35132-jubilant-cadista-meclizine-tablets-recall-incorrect-labeling-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/35132-jubilant-cadista-meclizine-tablets-recall-incorrect-labeling-risk · Updated August 18, 2026 · FDA enforcement record: FDA #D-0767-2022

Cite this page

“Jubilant Cadista Meclizine Tablets Recall: Incorrect Labeling Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35132-jubilant-cadista-meclizine-tablets-recall-incorrect-labeling-risk. Based on FDA recall #D-0767-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0767-2022%22&limit=1).

The FDA announced on March 8, 2022, that Jubilant Cadista Pharmaceuticals voluntarily recalled Meclizine Hydrochloride Tablets USP due to a labeling mix-up. The hazard involves bottles incorrectly labeled as PredniSONE Tablets.

How to tell if you have it

Brand: Jubilant Cadista
Product: Meclizine Hydrochloride Tablets USP, 12.5 mg
Packaging: Case of 24 bottles (100-count bottle)
NDC: 59746-122-06
Lot #: 22P0036
Expiration: 12/2024
Quantity: 12,174 bottles

The hazard

Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled as PredniSONE Tablets. The tablets in the bottles are Meclizine Hydrochloride.

Context

GovInfoNow's records show Jubilant Cadista Pharmaceuticals, Inc. has 24 other recalls on record since 2013-02-11. Other recent recalls of similar products include Jubilant Cadista Prochlorperazine Tablets Recall (2022-12-27), Jubilant Cadista recalls 75mg Irbesartan tablets (2022-07-18), and Jubilant Cadista Methylprednisolone Tablets 4mg Recall (2022-04-01). Other recent recalls of similar products include Meclizine 12.5mg Tablets Recall (2026-03-16), Sun Pharmaceutical Perampanel 6mg Tablets Recall (2026-06-17), and Annora Pharma Lacosamide Tablets Recall (2026-06-04).

How to tell if you have this one

Check for Meclizine Hydrochloride Tablets labeled as Prednisone. The product was sold in cases of 24 bottles (100-count bottle) with NDC 59746-122-06, manufactured in Salisbury, MD, Lot # 22P0036, expiring 12/2024.

Brand
Jubilant Cadista
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Label Carefully
Look for Meclizine Hydrochloride Tablets labeled as Prednisone. If found, do not use them.

Where it went and when

Where it was distributed

Distributed in 5 states.

FDA distribution: “Product was distributed in Arkansas, Florida, North Carolina, South Carolina and Ohio.” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Arkansas, Florida, North Carolina, Ohio, South Carolina.

Recall timeline

FDA terminated this recall 8 months after the firm started it.

Mar 8, 2022Firm started the recall
Apr 6, 2022Published in FDA’s Enforcement Report
Apr 12, 2022FDA classified it Class I
Nov 15, 2022FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/35132-jubilant-cadista-meclizine-tablets-recall-incorrect-labeling-risk">Jubilant Cadista Meclizine Tablets Recall: Incorrect Labeling Risk (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0767-2022 (March 8, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0767-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.